GROWTH FACTORS

Scope & Guideline

Illuminating the path from research to clinical application.

Introduction

Explore the comprehensive scope of GROWTH FACTORS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore GROWTH FACTORS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0897-7194
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1988 to 2020, from 2022 to 2024
AbbreviationGROWTH FACTORS / Growth Factors
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'GROWTH FACTORS' focuses on the biological mechanisms and therapeutic applications of growth factors and related molecular pathways in various diseases and conditions. It aims to advance the understanding of how growth factors influence cellular processes, tissue regeneration, and disease progression.
  1. Investigation of Growth Factor Mechanisms:
    Research examining the roles of specific growth factors in physiological and pathological processes, including their signaling pathways and molecular interactions.
  2. Therapeutic Applications of Growth Factors:
    Studies exploring the use of growth factors in clinical settings, such as wound healing, cancer treatment, and regenerative medicine.
  3. Cross-Disciplinary Approaches:
    Integration of various scientific disciplines, including molecular biology, pharmacology, and clinical research, to provide a comprehensive understanding of growth factors.
  4. Preclinical and Clinical Research:
    Emphasis on both laboratory-based studies and clinical trials to evaluate the efficacy and safety of growth factor therapies.
  5. Biomarker Identification and Validation:
    Research aimed at identifying biomarkers related to growth factor activity that can be used for prognosis and treatment response in diseases.
The journal has witnessed the emergence of several trending themes that reflect current scientific advancements and societal health challenges, particularly in the context of growth factors and their applications.
  1. Diabetes and Metabolic Disorders:
    An increasing focus on the role of growth factors in managing diabetes and related metabolic disorders, highlighting the importance of understanding their mechanisms in tissue regeneration and repair.
  2. Cancer Research and Therapeutics:
    A significant rise in studies investigating the role of growth factors in cancer biology, particularly in relation to tumor microenvironments, metastasis, and resistance to therapies.
  3. Regenerative Medicine and Tissue Engineering:
    Emerging research on the application of growth factors in regenerative medicine, including stem cell therapies and biomaterials for tissue repair.
  4. Neurobiology and Neurodegenerative Diseases:
    Growing interest in the neurotrophic factors and their implications in neurodegenerative diseases, emphasizing the potential for therapeutic interventions.
  5. Personalized Medicine Approaches:
    An evolving trend towards personalized medicine, utilizing growth factors as biomarkers for tailored treatment plans in various diseases.

Declining or Waning

While 'GROWTH FACTORS' has consistently focused on critical areas related to growth factors, certain themes appear to be declining in frequency, indicating a potential shift in research interests or advancements in the field.
  1. Basic Science of Growth Factors:
    There has been a noticeable decrease in studies centered solely on the basic biological properties of growth factors, as research increasingly emphasizes clinical applications and translational research.
  2. Traditional Cancer Therapies:
    Research related to conventional cancer therapies involving growth factors is less prevalent, possibly due to the rise of targeted therapies and immunotherapy approaches.
  3. Animal Models in Growth Factor Research:
    The reliance on animal models for growth factor studies seems to be waning, with a shift towards more human-centric research methodologies, including clinical trials.

Similar Journals

Protein & Cell

Unveiling Innovations in Drug Discovery and Biotechnology
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

Biomolecules & Therapeutics

Innovating Drug Discovery through Rigorous Science
Publisher: KOREAN SOC APPLIED PHARMACOLOGYISSN: 1976-9148Frequency: 4 issues/year

Biomolecules & Therapeutics is a prominent journal published by the Korean Society of Applied Pharmacology, dedicated to advancing knowledge in the fields of Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. With an ISSN of 1976-9148 and an E-ISSN of 2005-4483, this journal serves as a vital platform for researchers and professionals to disseminate their findings from 2008 through 2024. Ranking in the Q2 category across multiple relevant fields, including Pharmacology and Drug Discovery, and consistently placing in the 60th to 70th percentiles in Scopus rankings, Biomolecules & Therapeutics exemplifies a commitment to high-quality research and scientific integrity. Although it operates on a traditional access model, readers can be assured of the journal's rigorous peer-review process, ensuring that published articles contribute meaningfully to ongoing discourse in pharmacological and biochemical research. Located in Seoul, South Korea, the journal stands at the forefront of innovation in healthcare, making it an essential resource for academics, students, and industry professionals alike.

STEM CELLS AND DEVELOPMENT

Exploring the Potential of Stem Cells in Science
Publisher: MARY ANN LIEBERT, INCISSN: 1547-3287Frequency: 24 issues/year

STEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.

Cell and Bioscience

Exploring the Intersection of Science and Innovation
Publisher: BMCISSN: Frequency: 1 issue/year

Cell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.

Cell Regeneration

Fostering Collaboration in the Realm of Cell Regeneration
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Regeneration, published by SPRINGERNATURE, stands at the forefront of biological research, focusing on the dynamic field of cellular development and regenerative biology. Since its establishment in 2012, this journal has embraced an Open Access model, facilitating widespread dissemination of key findings and fostering collaboration among researchers in the Netherlands and beyond. With an impact factor underscoring its significance, Cell Regeneration is positioned in the Q2 category in both Cell Biology and Developmental Biology as of 2023, ranked #32 out of 82 and #170 out of 285 in relevant Scopus peer fields. The journal encompasses a broad spectrum of research that advances our understanding of cellular processes, offering vital insights into regenerative mechanisms and their applications in therapies. This robust platform not only serves as a valuable resource for researchers, professionals, and students but also encourages scholarly dialogue and innovation in the fast-evolving landscape of cell biology.

Stem Cells International

Unlocking the Potential of Regenerative Medicine
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Organogenesis

Advancing the Frontiers of Developmental Biology.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

BIOLOGICAL PROCEDURES ONLINE

Unlocking Innovations in Biochemistry and Genetics.
Publisher: BMCISSN: Frequency: 1 issue/year

BIOLOGICAL PROCEDURES ONLINE is a premier open-access journal published by BMC, dedicated to advancing the fields of biochemistry, genetics, and molecular biology. With its electronic ISSN 1480-9222 and a strong commitment to accessibility since 2009, this journal provides a vital platform for researchers and scholars to disseminate their findings and foster collaboration within the scientific community. Based in the United Kingdom, this journal has garnered an impressive reputation, achieving Q1 status in the 2023 category rankings, with notable inclusion in the Scopus rankings, placing it in the 86th percentile among 221 peer journals in the general biochemistry, genetics, and molecular biology domain. It covers a broad range of topics, ensuring coverage of the latest advancements and methodologies in biological procedures, making it an essential resource for academics, practitioners, and students alike. Researchers are encouraged to submit their innovative work and contribute to the ongoing dialogue in this dynamic and ever-evolving field.

Journal of Stem Cells & Regenerative Medicine

Pioneering Research for a Healthier Tomorrow
Publisher: JOURNAL STEM CELLS & REGENERATIVE MEDICINEISSN: 0973-7154Frequency: 2 issues/year

The Journal of Stem Cells & Regenerative Medicine is a leading publication dedicated to the advancing field of stem cell research and regenerative medicine. Established in India and published by JOURNAL STEM CELLS & REGENERATIVE MEDICINE, this Open Access journal has been available since 2007, providing researchers and practitioners with free and unrestricted access to high-quality articles. With an ISSN of 0973-7154, the journal is indexed in Scopus, featuring a wide array of topics and insights into biochemistry, biotechnology, cell biology, and molecular biology, as denoted by its relevant quartile rankings. This journal is committed to bridging the gap between laboratory research and clinical applications, making significant contributions to the scientific community. The convergence of innovative studies from 2010 to 2024 positions it as an invaluable resource for those looking to stay at the forefront of stem cell and regenerative medicine research.

Cell Communication and Signaling

Unleashing Insights into Cell Communication Dynamics
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.